These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 22307441)
1. Creatinine clearance, cystatin C, beta2-microglobulin and TATI as markers of renal function in patients with proteinuria. Tramonti G; Cipollini I; Annichiarico C; Lorusso P; Panicucci E; Mariani G; Barsotti G J Nephrol; 2012; 25(6):976-82. PubMed ID: 22307441 [TBL] [Abstract][Full Text] [Related]
2. Assessment of tumor-associated trypsin inhibitor (TATI) as a marker of renal function. Tramonti G; Ferdeghini M; Annichiarico C; Donadio C; Norpoth M; Mantuano E; Bianchi C J Nephrol; 2003; 16(5):663-72. PubMed ID: 14733412 [TBL] [Abstract][Full Text] [Related]
3. Comparison of renal function markers in Kuwaiti patients with sickle cell disease. Marouf R; Mojiminiyi O; Abdella N; Kortom M; Al Wazzan H J Clin Pathol; 2006 Apr; 59(4):345-51. PubMed ID: 16567469 [TBL] [Abstract][Full Text] [Related]
4. Cystatin C and beta2-microglobulin: markers of glomerular filtration in critically ill children. Herrero-Morín JD; Málaga S; Fernández N; Rey C; Diéguez MA; Solís G; Concha A; Medina A Crit Care; 2007; 11(3):R59. PubMed ID: 17519026 [TBL] [Abstract][Full Text] [Related]
5. Can cystatin C be a better marker for the early detection of renal damage in primary hypertensive patients? Ozer BA; Dursun B; Baykal A; Gultekin M; Suleymanlar G Ren Fail; 2005; 27(3):247-53. PubMed ID: 15957539 [TBL] [Abstract][Full Text] [Related]
6. Cystatin C is not more sensitive than creatinine for detecting early renal impairment in patients with diabetes. Oddoze C; Morange S; Portugal H; Berland Y; Dussol B Am J Kidney Dis; 2001 Aug; 38(2):310-6. PubMed ID: 11479157 [TBL] [Abstract][Full Text] [Related]
7. Cystatin C, Beta2 Microglobulin, N-Acetyl-beta-D-glucosaminidase, Retinol-Binding Protein, and Endothelin 1 Levels in the Evaluation of Sickle Cell Disease Nephropathy. Unal S; Kotan C; Delibas A; Oztas Y Pediatr Hematol Oncol; 2015 May; 32(4):250-7. PubMed ID: 23987825 [TBL] [Abstract][Full Text] [Related]
8. Tumor-associated trypsin inhibitor (TATI) and renal function. Tramonti G; Ferdeghini M; Donadio C; Annichiarico C; Norpoth M; Bianchi R; Bianchi C Kidney Int Suppl; 1997 Dec; 63():S179-81. PubMed ID: 9453997 [TBL] [Abstract][Full Text] [Related]
9. GFR prediction using the MDRD and Cockcroft and Gault equations in patients with end-stage renal disease. Kuan Y; Hossain M; Surman J; El Nahas AM; Haylor J Nephrol Dial Transplant; 2005 Nov; 20(11):2394-401. PubMed ID: 16115853 [TBL] [Abstract][Full Text] [Related]
10. Cystatin C and blood pressure: results of 24 h ambulatory blood pressure monitoring. Mena C; Robles NR; de Prado JM; Gallego FG; Cidoncha A Eur J Intern Med; 2010 Jun; 21(3):185-90. PubMed ID: 20493420 [TBL] [Abstract][Full Text] [Related]
11. Value of serum cystatin C as a marker of renal function in the early post kidney transplant period. Geramizadeh B; Azarpira N; Ayatollahi M; Rais-Jalali GA; Aghdai M; Yaghoobi R; Banihashemi M; Malekpour Z; Malek-Hosseini SA Saudi J Kidney Dis Transpl; 2009 Nov; 20(6):1015-7. PubMed ID: 19861863 [TBL] [Abstract][Full Text] [Related]
12. Performance of methods to assess kidney function in a predominantly overweight sample of patients with liver disease. Hudson JQ; Owens HM; Fleckenstein JF; Loveless VS; Krauss AG; Hak LJ Ren Fail; 2013; 35(2):249-56. PubMed ID: 23176438 [TBL] [Abstract][Full Text] [Related]
13. Serum cystatin C level for better assessment of glomerular filtration rate in cystic fibrosis patients treated by amikacin. Halacova M; Kotaska K; Kukacka J; Vavrova V; Kuzelova M; Ticha J; Prusa R J Clin Pharm Ther; 2008 Aug; 33(4):409-17. PubMed ID: 18613859 [TBL] [Abstract][Full Text] [Related]
14. The effects of proteinuria on urinary cystatin-C and glomerular filtration rate calculated by serum cystatin-C. Kim JS; Kim MK; Lee JY; Han BG; Choi SO; Yang JW Ren Fail; 2012; 34(6):676-84. PubMed ID: 22607020 [TBL] [Abstract][Full Text] [Related]
15. Kidney function estimating equations in patients with chronic kidney disease. Hojs R; Bevc S; Ekart R; Gorenjak M; Puklavec L Int J Clin Pract; 2011 Apr; 65(4):458-64. PubMed ID: 21401834 [TBL] [Abstract][Full Text] [Related]
16. Cystatin C: influence of perfusion and myocardial injury on early (<24 h) renal function after pediatric cardiac surgery. Vassalos A; Young D; MacArthur K; Pollock J; Lyall F; Danton MH Paediatr Anaesth; 2011 Dec; 21(12):1185-91. PubMed ID: 21831111 [TBL] [Abstract][Full Text] [Related]
17. Serum and urinary markers of early impairment of GFR in chronic kidney disease patients: diagnostic accuracy of urinary β-trace protein. Donadio C Am J Physiol Renal Physiol; 2010 Dec; 299(6):F1407-23. PubMed ID: 20844024 [TBL] [Abstract][Full Text] [Related]
18. [Evaluation of glomerular filtration rate in children--serum markers and prediction equations]. Nakai K; Kikuchi M; Koyamaa T; Saito K; Suwabe A Rinsho Byori; 2009 Apr; 57(4):338-44. PubMed ID: 19489435 [TBL] [Abstract][Full Text] [Related]
19. Cystatin C as a marker of renal function immediately after liver transplantation. Biancofiore G; Pucci L; Cerutti E; Penno G; Pardini E; Esposito M; Bindi L; Pelati E; Romanelli A; Triscornia S; Salvadorini MP; Stratta C; Lanfranco G; Pellegrini G; Del Prato S; Salizzoni M; Mosca F; Filipponi F Liver Transpl; 2006 Feb; 12(2):285-91. PubMed ID: 16447198 [TBL] [Abstract][Full Text] [Related]
20. The value of estimated GFR in comparison to measured GFR for the assessment of renal function in adult patients with Fabry disease. Rombach SM; Baas MC; ten Berge IJ; Krediet RT; Bemelman FJ; Hollak CE Nephrol Dial Transplant; 2010 Aug; 25(8):2549-56. PubMed ID: 20215390 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]